Pay in 4 interest-free payments of $17.25 Learn more
Ships within 48 hours · Estimated delivery Nov 4 - Nov 9
InChi: InChI=1S/C28H30ClN5O4S/c1-17-25(30-18(2)26(17)28(36)34-12-10-32(3)11-13-34)16-23-22-15-21(8-9-24(22)31-27(23)35)39(37
5]thiazolo[3
most selective 5- HT2B receptor ligands
Formula: C28H30N2O6S
MDV-3100 also prevents nuclear translocation and co-activator recruitment of the ligand-receptor complex
MBX-2982 - CAS# 1037792-44-1 size:2mg solid InChi: InChI=1S/C28H30ClN5O4S/c1-17-25(30-18(2)26(17)28(36)34-12-10-32(3)11-13-34)16-23-22-15-21(8-9-24(22)31-27(23)35)39(37MBX 2982, also known as SAR 260093, CAS No. 1037792 44 1, is a potential first in class treatment for type 2 diabetes that targets G protein coupled receptor 119 (GPR119), a receptor that interacts with bioactive lipids known to stimulate glucose dependent insulin secretion. Preclinical data indicate that MBX 2982 is a potent selective orally active GPR119 agonist that functions through a unique dual mechanism of action. First, it acts directly on the
US$ 27.99
US$ 190.95
US$ 44.95
US$ 54.99
US$ 109.00
US$ 10.99
US$ 18.99
US$ 12.49
US$ 66.00
US$ 149.95